Screening for Type 2 Diabetes by Oral Glucose Tolerance Test in the Population Groups Not Diagnosed by Fasting Blood Glucose in Guadeloupe: a Pilot Study
Status: Recruiting
Location: See location...
Intervention Type: Diagnostic test
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
In France, only the fasting blood glucose (FBG) measurement is recommended for diabetes screening. Ethnic heterogeneity and genetic polymorphisms specific to the Afro-Caribbean and Indo-Caribbean population in Guadeloupe justify the interest to early screen type 2 diabetes mellitus (T2DM). Our main objective is to estimate the prevalence of T2DM defined by oral glucose tolerance (OGTT) in subjects with risk factors for T2DM and not diagnosed with the FBG.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 65
Healthy Volunteers: t
View:
• Affiliation to the national social health system or equivalent Informed and written consent signed by the patient and the investigator (at the latest on the day of inclusion and before the completion of any research related exam)
Locations
Other Locations
Guadeloupe
Centre Hospitalier Universitaire de la Guadeloupe
RECRUITING
Pointe-à-pitre
Contact Information
Primary
Valérie HAMONY-SOTER
valerie.soter@chu-guadeloupe.fr
+590 590 93 46 77
Backup
Eunice NUBRET
eunice.nubret@chu-guadeloupe.fr
Time Frame
Start Date: 2021-02-02
Estimated Completion Date: 2028-08-02
Participants
Target number of participants: 120
Treatments
Experimental: non diabetic
After inclusion, the subjects will have an OGTT performed in the department of non-diabetic subjects in Guadeloupe, from African or Indian origin who have risk factors of diabetes associated with normal FBG levels but HbA1c levels between 5.7 and 6.4%.
Related Therapeutic Areas
Sponsors
Leads: Centre Hospitalier Universitaire de la Guadeloupe